开放期刊系统

探讨婴幼儿血管瘤与高钾血症的关系

王 淑慧, 关 小珊, 陈 小红, 邝 婉仪, 林爱 君*

摘要

目的 探讨国内婴幼儿血管瘤患儿是否存在高钾血症及其可能的病因。方法 本次研究以来自于我院在2024年1月到2024年12月期间收治的489例血管瘤患儿和386例健康体检者作为研究对象, 参考行业标准WST 780-2021《儿童临床常用生化检验项目参考区间》对其血清钾进行回顾性研究,分析血管瘤患儿血清钾与疾病本身、白细胞、血小板、年龄等指标的关系。结果 婴儿疾病组血钾浓度与婴儿对照组、幼儿疾病组患儿血钾浓度之间的差异有统计学意义(P=0.00<0.05),幼儿疾病组血钾浓度与幼儿对照组血钾浓度之间的差异没有统计学意义(P=0.08>0.05)。婴儿疾病组血钾浓度与PLT呈正相关(r=0.257,P=0.00<0.05);与年龄呈负相关,(r=-0.485,P=0.00<0.05);与WBC尚不能认为具有相关性(r=0.012,P=0.808>0.05)。结论:婴儿血管瘤患儿常伴有血钾异常升高,受年龄、血小板、用药和血管瘤本身病理变化影响。患儿易发生高钾血症,临床上应关注婴儿血管瘤患儿血钾变化。

关键词

血管瘤;婴幼儿;高钾血症

全文:

PDF

参考

[1]刘小烨,齐蔓莉.婴幼儿血管瘤发病机制研究进展[J].中国麻风皮肤病杂志,2023,39(1):61-64.

[2]儿童临床常用生化检验项目参考区间.中华人民共和国卫生行业标准WS/T 780-2021[S].

[3]Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma[J].Pediatrics.2010,126(6):e1589-e1593.

[4]Belen B, Oguz A, Okur A, et al. A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis[J]. BMJ Case Rep. 2014,2014.

[5]Ji Y, Chen S, Wang Q, et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management[J]. Sci Rep.2018,8(1):4264.

[6]Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma[J].JAAD Case Rep.2020,6(4): 359-361.

[7]Dreyfus I,Maza A,Mazereeuw-Hautier J.[What's new about infantile hemangiomas?][J].ARCHIVES DE PEDIATRIE.2013;20(7):809-16.

[8] Cavalli R, Buffon R B, de Souza M, et al. Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding?[J]. Dermatology.2012,224(2):106-109.

[9]Leaute Labreze C, de la Roque ED, Hubiche T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med 2008;358:2649–51.

[10]Erbay A, Sarialioglu F, Malbora B, et al. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants[J]. Turk J Pediatr 2010;52:450–6.

[11]Palmer Biff F,Clegg Deborah J.Extrarenal Effects of Aldosterone on Potassium Homeostasis[J].Kidney360.2022;3 (3):561-568.

[12]Kupeli S. Use of propranolol for infantile hemangiomas[J]. Pediatr Hematol Oncol 2012;29:293–8.

[13]Storch CH, Hoeger PH. Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action[J].Br J Dermatol 2010;163:269–74.


(0 摘要 Views, 0 PDF Downloads)

Refbacks

  • 当前没有refback。